PT  - JOURNAL ARTICLE
AU  - Tarek Samy Abdelaziz
AU  - Eman Elsayed
AU  - Moataz Fatthy
TI  - Disruption of the renal service during COVID-19 pandemic, physicians survey responses from 5 countries
AID  - 10.1101/2020.06.30.20143354
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.06.30.20143354
4099  - http://medrxiv.org/content/early/2020/07/03/2020.06.30.20143354.short
4100  - http://medrxiv.org/content/early/2020/07/03/2020.06.30.20143354.full
AB  - The outbreak of COVID-19 has significant impact on health care systems. The workflow in renal care facilities and dialysis facilities is complex. The aim of his study was to explore multinational renal physician perspective about the disruption of outflow of renal service amid COVID-19 pandemic.Methods we distributed a questionnaire electronically to renal physicians of various grades from 5 countries. The questionnaire was formulated of 9 questions with domains centered on the acute and chronic renal servicesResults 97 physicians took part in the survey from 5 countries. 58% of the participating renal physicians agreed that there has been disruption to the acute service offered to renal patients. 38% of the physicians who took the survey report disruption to the hemodialysis facilities.Conclusion At this challenging time of the pandemic, it is important to perform audits and quality control to explore the deficiencies of acute and chronic renal care pathways.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Kasr-Alainy REC deemed ethical approval not requiredAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesavailable upon request